Suppr超能文献

[结直肠癌恶性潜能的流式细胞术DNA分析——DNA倍体模式与肝转移]

[Flow cytometric DNA analysis of malignant potential in colorectal carcinoma--DNA ploidy pattern and liver metastasis].

作者信息

Funai S, Kurooka K, Matsuda T, Ushida S, Sagara N, Shindo K, Yasutomi M

机构信息

First Department of Surgery, Kinki University School of Medicine, Osaka Sayama, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 1991 Feb;92(2):127-32.

PMID:2038287
Abstract

On the purpose of elucidating the malignant potential, flow cytometric DNA analyses were carried out using paraffin-embedded materials of 82 subserosal, serosal and adventitial invasive colorectal carcinoma. The ratio of DNA diploidy against DNA aneuploidy was one to two. DNA ploidy pattern was not correlated with histological grade but with histopathological factors such as lymphatic permeation, lymph node metastasis and venous invasion. At the primary operation, the rate of the liver metastasis in DNA aneuploid cancer was 16.4% but in DNA diploid cancer the liver metastasis was not observed at all. On the liver metastasis, the 5-year disease free survival rates were lower in patients with DNA aneuploidy (72.8%) than those with DNA diploidy (95.2%). These results indicate that DNA ploidy pattern is related to liver metastasis. Furthermore, the 5-year survival rates in patients with absolute curative resection were lower significantly in DNA aneuploidy (62.5%) than DNA diploidy (92.9%). In conclusion flow cytometric DNA analysis is useful for evaluating the biological malignant potential and predicting the liver metastasis in colorectal carcinoma.

摘要

为了阐明恶性潜能,对82例浆膜下、浆膜和外膜浸润性结直肠癌的石蜡包埋材料进行了流式细胞术DNA分析。DNA二倍体与DNA非整倍体的比例为1比2。DNA倍体模式与组织学分级无关,但与淋巴管浸润、淋巴结转移和静脉浸润等组织病理学因素有关。在初次手术时,DNA非整倍体癌的肝转移率为16.4%,而DNA二倍体癌根本未观察到肝转移。关于肝转移,DNA非整倍体患者的5年无病生存率(72.8%)低于DNA二倍体患者(95.2%)。这些结果表明DNA倍体模式与肝转移有关。此外,绝对根治性切除患者的5年生存率在DNA非整倍体患者(62.5%)中显著低于DNA二倍体患者(92.9%)。总之,流式细胞术DNA分析有助于评估结直肠癌的生物学恶性潜能并预测肝转移。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验